Abstract
Following the UK’s organ retention scandals that occurred a decade ago, politicians unleashed a deluge of well-intentioned but naïve and unnecessarily burdensome regulations that have progressively stymied human tissue-based research, stifling development of improved diagnostic and prognostic tests as well as discovery of new treatments based on sound knowledge of human-specific biology. For the UK to maintain a leading role in medical research, more sensible levels of regulation need to be introduced that recognise differences between tissue from donors who have passed-away and surgical tissue that is surplus to diagnostic requirements and that otherwise will be incinerated. While it is important to reassure the public that research using their tissues will be conducted within an approved ethical framework, it is equally important to ensure that, as hospital staff and academic researchers, we are able to fulfil our unwritten covenant with patients to do our utmost to seek better diagnostic assays and more predictive prognostic indicators, while collaborating with our colleagues in academia and industry and hence bring hope to patients with illnesses for which no effective treatments are yet available. There is a clear case for introducing an opt-out system as the default to allow all surplus surgical tissues to be immediately available for research, concomitant with an education campaign. This is the optimal and most ethical approach to ensure the wishes of the vast majority of patients are respected by allowing their residual surgical tissues and relevant clinical information to be made available for research without the current levels of obstruction and hindrance.
Similar content being viewed by others
References
Clemente J et al (2008) Pharmaceutical expenditure, total health-care expenditure and GDP. Health Econ 17:1187–1206
Foster CS, Dodson AR, Ambroisine L et al (2009) Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. Br J Cancer 101:1137–1144
National Cancer Research Institute Pathology Taskforce (2009) Fostering the role of pathology in research 2009. http://www.ncri.org.uk/includes/publications/reports/NCRI_PathologyReport_electronic2.pdf
Scattereggia J (2010) Financial Times Global Pharmaceutical & Biotechnology Conference 2009. IDrugs 13:26–29
Tay SK et al (2009) Global discovery of primate-specific genes in the human genome. Proc Natl Acad Sci USA 106:12019–12024
Varki A et al (2008) Explaining human uniqueness: genome interactions with environment, behaviour and culture. Nat Rev Genet 9:749–763
Yao S, Bee A, Brewer D et al (2010) PRKC-ζ Expression promotes the aggressive phenotype of human prostate cancer cells and is a novel target for therapeutic intervention. Genes Cancer 1:444–464
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foster, C.S. Pathology: coming in from the cold. Cell Tissue Bank 12, 25–27 (2011). https://doi.org/10.1007/s10561-010-9211-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-010-9211-7